share_log

CORRESP: CORRESP

CORRESP: CORRESP

CORRESP:信函
美股SEC公告 ·  2024/09/10 10:33

Moomoo AI 已提取核心訊息

ZyVersa Therapeutics, Inc. has officially requested the U.S. Securities and Exchange Commission (SEC) to declare its Registration Statement on Form S-3 effective as of September 9, 2024, at 5:00 p.m. Eastern Time. The request, made under Rule 461 of the Securities Act of 1933, as amended, was submitted through a correspondence filed via EDGAR. The company, based in Weston, Florida, has indicated that the effective date and time are subject to change if they notify the SEC otherwise. ZyVersa's CEO, Stephen C. Glover, signed the request, and the company's outside counsel, Faith L. Charles of Thompson Hine LLP, is the point of contact for any inquiries related to this matter.
ZyVersa Therapeutics, Inc. has officially requested the U.S. Securities and Exchange Commission (SEC) to declare its Registration Statement on Form S-3 effective as of September 9, 2024, at 5:00 p.m. Eastern Time. The request, made under Rule 461 of the Securities Act of 1933, as amended, was submitted through a correspondence filed via EDGAR. The company, based in Weston, Florida, has indicated that the effective date and time are subject to change if they notify the SEC otherwise. ZyVersa's CEO, Stephen C. Glover, signed the request, and the company's outside counsel, Faith L. Charles of Thompson Hine LLP, is the point of contact for any inquiries related to this matter.
ZyVersa Therapeutics, Inc.已正式向美國證券交易委員會(SEC)請求宣佈其關於Form S-3的註冊聲明在2024年9月9日下午5:00(東部時間)生效。根據1933年證券法修訂案的第461條規定,該請求是通過EDGAR提交的函電。位於佛羅里達州韋斯頓的該公司指出,生效日期和時間如有變動,將及時通知SEC。ZyVersa的首席執行官Stephen C. Glover簽署了該請求,公司的外部法律顧問Thompson Hine LLP的Faith L. Charles是與此事有關的任何查詢的聯繫人。
ZyVersa Therapeutics, Inc.已正式向美國證券交易委員會(SEC)請求宣佈其關於Form S-3的註冊聲明在2024年9月9日下午5:00(東部時間)生效。根據1933年證券法修訂案的第461條規定,該請求是通過EDGAR提交的函電。位於佛羅里達州韋斯頓的該公司指出,生效日期和時間如有變動,將及時通知SEC。ZyVersa的首席執行官Stephen C. Glover簽署了該請求,公司的外部法律顧問Thompson Hine LLP的Faith L. Charles是與此事有關的任何查詢的聯繫人。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息